Ambu Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Ambu wird ein jährliches Gewinn- und Umsatzwachstum von 26% bzw. 11.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 26.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12% betragen.

Wichtige Informationen

21.2%

Wachstumsrate der Gewinne

22.1%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	19.0%
Wachstumsrate der Einnahmen	11.5%
Zukünftige Eigenkapitalrendite	12.1%
Analystenabdeckung	Good
Zuletzt aktualisiert	16 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Sep 02

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

Recent updates

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Jun 06

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

May 19

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Jan 23

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Dec 12

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Oct 04

Gewinn- und Umsatzwachstumsprognosen

CPSE:AMBU B - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (DKK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
9/30/2027	7,691	1,031	N/A	N/A	2
9/30/2026	6,904	850	638	1,089	5
9/30/2025	6,108	661	535	950	6
9/30/2024	5,421	508	473	814	6
6/30/2024	5,263	450	614	893	N/A
3/31/2024	5,075	367	608	902	N/A
12/31/2023	4,897	238	501	805	N/A
9/30/2023	4,775	168	192	518	N/A
6/30/2023	4,679	-42	-168	217	N/A
3/31/2023	4,612	-65	-318	119	N/A
12/31/2022	4,545	95	-475	25	N/A
9/30/2022	4,444	93	-463	95	N/A
6/30/2022	4,307	222	-401	185	N/A
3/31/2022	4,152	256	-521	107	N/A
12/31/2021	4,031	176	-419	194	N/A
9/30/2021	4,013	247	-256	328	N/A
6/30/2021	3,858	251	-187	347	N/A
3/31/2021	3,832	281	111	593	N/A
12/31/2020	3,820	290	56	511	N/A
9/30/2020	3,567	241	-135	295	N/A
6/30/2020	3,302	146	-24	366	N/A
3/31/2020	3,128	270	-62	277	N/A
12/31/2019	2,924	296	37	330	N/A
9/30/2019	2,820	317	272	533	N/A
6/30/2019	2,943	515	361	597	N/A
3/31/2019	2,843	411	316	553	N/A
12/31/2018	2,709	372	327	560	N/A
9/30/2018	2,606	337	318	554	N/A
6/30/2018	2,506	318	269	498	N/A
3/31/2018	2,434	288	N/A	456	N/A
12/31/2017	2,396	281	N/A	476	N/A
9/30/2017	2,355	301	N/A	462	N/A
6/30/2017	2,299	306	N/A	403	N/A
3/31/2017	2,215	299	N/A	460	N/A
12/31/2016	2,134	267	N/A	420	N/A
9/30/2016	2,084	250	N/A	369	N/A
6/30/2016	2,047	224	N/A	408	N/A
3/31/2016	2,012	169	N/A	269	N/A
12/31/2015	1,963	175	N/A	246	N/A
9/30/2015	1,889	152	N/A	208	N/A
6/30/2015	1,795	171	N/A	141	N/A
3/31/2015	1,710	184	N/A	137	N/A
12/31/2014	1,630	156	N/A	147	N/A
9/30/2014	1,584	151	N/A	183	N/A
6/30/2014	1,543	94	N/A	167	N/A
3/31/2014	1,524	67	N/A	141	N/A
12/31/2013	1,456	40	N/A	148	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AMBU BDas prognostizierte Gewinnwachstum (26% pro Jahr) liegt über der Sparquote (1%).

Ertrag vs. Markt: AMBU BDie Erträge des Unternehmens (26% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Danish (14.2% pro Jahr).

Hohe Wachstumserträge: AMBU BEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AMBU BDie Einnahmen des Unternehmens (11.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Danish (11% pro Jahr).

Hohe Wachstumseinnahmen: AMBU BDie Einnahmen des Unternehmens (11.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AMBU BDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12%).

Ambu Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Price target increased by 8.1% to kr.123

Consensus EPS estimates increase by 14%

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Recent updates

Ambu A/S to Report Fiscal Year 2025 Results on Nov 05, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings: EPS exceeds analyst expectations

Price target increased by 8.1% to kr.123

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Consensus forecasts updated

Second quarter 2022 earnings: Revenues in line with analyst expectations

Price target decreased to kr.137

Less than half of directors are independent